Patents by Inventor Nick Vandegraaff

Nick Vandegraaff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9738941
    Abstract: Methods for screening a multiplicity of respiratory pathogens by isolating nucleic acids from a sample include isolating a nucleic acid from a sample and using solid phase amplification with forward primers SEQ ID NOs: 1 to 16 or 33 or 35 and corresponding reverse primers SEQ ID NOs: 17 to 32 or 34 or 36 along with probes to generate amplicons. The method further includes employing bead sets which are homogenous with respect to bead size and optionally with respect to the intensity of the label. Binding of a particular amplicon to a subset of beads determines the identity of the respiratory pathogen.
    Type: Grant
    Filed: October 4, 2012
    Date of Patent: August 22, 2017
    Assignee: Genera Biosystems Limited
    Inventors: Karl Frederick Poetter, Nick Vandegraaff
  • Publication number: 20140309138
    Abstract: The present disclosure is instructional for a multiplex nucleic acid amplification assay to detect and identify multiple respiratory pathogens.
    Type: Application
    Filed: October 4, 2012
    Publication date: October 16, 2014
    Inventors: Karl Frederick Poetter, Nick Vandegraaff